subject area of

• A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy - Adjuvant Versus Early Salvage (RAVES) trial  Academic Article
• A clinical and echocardiographic score for assigning risk of major events after dobutamine echocardiograms  Academic Article
• A multicenter, randomized trial of a nurse-led, home-based intervention for optimal secondary cardiac prevention suggests some benefits for men but not for women  Academic Article
• A negative confirmatory biopsy among men on active surveillance for prostate cancer does not protect them from histologic grade progression  Academic Article
• A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumors  Academic Article
• A phase II trial of primary temozolomide in patients with grade III oligodendroglial brain tumors  Academic Article
• A phase II trial with anti-Lewis-Y monoclonal antibody (hu3S193) for the treatment of platinum resistant/refractory ovarian, fallopian tube and primary peritoneal carcinoma  Conference Paper
• A randomized phase II study of FOLFOX with or without the MET inhibitor onartuzumab in advanced Adenocarcinoma of the stomach and Gastroesophageal junction  Academic Article
• A single centre study of the treatment of relapsed primary central nervous system lymphoma (PCNSL) with single agent temozolomide  Academic Article
• A single-centre experience of patients with metastatic melanoma enrolled in a dabrafenib named patient programme  Academic Article
• Adherence to the Mediterranean Diet in Relation to Ischemic Stroke Nonfatal Events in Nonhypercholesterolemic and Hypercholesterolemic Participants  Academic Article
• Advances in local and ablative treatment of oligometastasis in prostate cancer  Academic Article
• Amino acid change in the carbohydrate response element binding protein is associated with lower triglycerides and myocardial infarction incidence depending on level of adherence to the mediterranean diet in the PREDIMED trial  Academic Article
• Arrhythmic risk assessment in genotyped families with arrhythmogenic right ventricular cardiomyopathy  Academic Article
• Arrhythmogenic right ventricular cardiomyopathy caused by deletions in plakophilin-2 and plakoglobin (Naxos disease) in families from Greece and Cyprus: genotype-phenotype relations, diagnostic features and prognosis  Academic Article
• Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17  Academic Article
• Atrial premature complexes and heart rate have prognostic significance in 1-month atrial fibrillation recurrence after electrical cardioversion  Academic Article
• BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian ovarian cancer study group  Academic Article
• Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: A subgroup analysis from the AGITG MAX trial: An international randomised controlled trial of capecitabine, bevacizumab and mitomycin C  Academic Article
• Biomarker Glycoprotein Acetyls is Associated with the Risk of a Wide Spectrum of Incident Diseases and Stratifies Mortality Risk in Angiography Patients  Academic Article
• Body mass index is prognostic in metastatic colorectal cancer: Pooled analysis of patients from first-line clinical trials in the ARCAD database  Academic Article
• Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate  Academic Article
• Cediranib plus FOLFOX/CAPOX versus placebo plus FOLFOX/CAPOX in patients with previously untreated metastatic colorectal cancer: a randomized, double-blind, phase III study (HORIZON II)  Academic Article
• Combined BRAF (dabrafenib) and MEK inhibition (trametinib) in patients with BRAF V600 -mutant melanoma experiencing progression with single-agent BRAF inhibitor  Academic Article
• Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations  Academic Article
• Comparative Prediction of Cardiac Events by Wall Motion, Wall Motion Plus Coronary Flow Reserve, or Myocardial Perfusion Analysis: A Multicenter Study of Contrast Stress Echocardiography  Academic Article
• Current and evolving methods to visualize biological data in cancer research  Academic Article
• Decision analysis of tamoxifen for the prevention of invasive breast cancer  Academic Article
• Detection of Circulating Tumor Cells in Colorectal Cancer by Immunobead-PCR Is a Sensitive Prognostic Marker for Relapse of Disease  Academic Article
• Dual targeting of the epidermal growth factor receptor using the combination of cetuximab and erlotinib: preclinical evaluation and results of the phase II DUX study in chemotherapy-refractory, advanced colorectal cancer  Academic Article
• Effect of aggressive risk factor modification on cardiac events and myocardial ischaemia in patients with chronic kidney disease  Academic Article
• Efficacy and safety of bevacizumab in metastatic colorectal cancer: Pooled analysis from seven randomized controlled trials  Academic Article
• Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastoma.  Academic Article
• Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases  Academic Article
• Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer  Academic Article
• Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer  Academic Article
• Everolimus for previously treated advanced gastric cancer: Results of the randomized, double-blind, phase III GRANITE-1 study  Academic Article
• Fc-gamma Receptor Polymorphisms, Cetuximab Therapy, and Survival in the NCIC CTG CO.17 Trial of Colorectal Cancer  Academic Article
• Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas  Academic Article
• Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab  Academic Article
• Hepatocellular carcinoma and chemoembolization  Academic Article
• Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancer  Academic Article
• Hyaluronan-Irinotecan improves progression-free survival in 5-fluorouracil refractory patients with metastatic colorectal cancer: A randomized phase II trial  Academic Article
• ICECREAM: Randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumours  Academic Article
• Imaging-Guided Cardioprotective Treatment in a Community Elderly Population of Stage B Heart Failure  Academic Article
• Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™  Academic Article
• Impact of Nurse-Led, Multidisciplinary Home-Based Intervention on Event-Free Survival Across the Spectrum of Chronic Heart Disease  Academic Article
• Impact of a nurse-led home and clinic-based secondary prevention programme to prevent progressive cardiac dysfunction in high-risk individuals: the Nurse-led Intervention for Less Chronic Heart Failure (NIL-CHF) randomized controlled study  Academic Article
• In Patients Experiencing Biochemical Failure After Radiotherapy, Pretreatment Risk Group and PSA Velocity Predict Differences in Overall Survival and Biochemical Failure-Free Interval  Academic Article
• Incremental Value of Rubidium-82 Positron Emission Tomography for Prognostic Assessment of Known or Suspected Coronary Artery Disease  Academic Article
• Incremental cost-effectiveness of exercise echocardiography vs. SPECT imaging for the evaluation of stable chest pain  Academic Article
• Individual patient data analysis of progression-free survival versus overall survival as a first-line end point for metastatic colorectal cancer in modern randomized trials: Findings from the analysis and research in cancers of the digestive system database  Academic Article
• Interval to biochemical recurrence following radical prostatectomy does not affect survival in men with low-risk prostate cancer  Academic Article
• Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy  Academic Article
• Is modern external beam radiotherapy with androgen deprivation therapy still a viable alternative for prostate cancer in an era of robotic surgery and brachytherapy: A comparison of Australian series  Academic Article
• Ixazomib for relapsed or refractory multiple myeloma: review from an evidence review group on a NICE single technology appraisal  Academic Article
• Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17  Academic Article
• Long-term results of a strategy of aortic valve repair in the pediatric population  Academic Article
• Metabolic response evaluation for colorectal liver metastases and correlation to pathologic response and tumour markers.  Academic Article
• Metastasis-free survival is a strong surrogate of overall survival in localized prostate cancer  Academic Article
• Multiparametric magnetic resonance imaging for prostate cancer - a comparative study including radical prostatectomy specimens  Academic Article
• Myelodysplastic syndrome incidence, transfusion dependence, health care use, and complications: an Australian population-based study 1998 to 2008  Academic Article
• Na+/monocarboxylate transport (SMCT) protein expression correlates with survival in colon cancer: Molecular characterization of SMCT  Academic Article
• Neoadjuvant Capecitabine and Oxaliplatin Followed by Synchronous Chemoradiation and Total Mesorectal Excision in Magnetic Resonance Imaging–Defined Poor-Risk Rectal Cancer  Academic Article
• Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma  Academic Article
• Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial  Academic Article
• Nintedanib Plus Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma: Phase II Results From the Randomized, Placebo-Controlled LUME-Meso Trial  Academic Article
• Nuclear HIF1A expression is strongly prognostic in sporadic but not familial male breast cancer  Academic Article
• Oral versus intravenous fluoropyrimidines for colorectal cancer  Academic Article
• Outcomes After Operations for Bicuspid Aortic Valve Disease in the Pediatric Population  Academic Article
• Outcomes of Older Patients (≥ 70 Years) Treated With Targeted Therapy in Metastatic Chemorefractory Colorectal Cancer: Retrospective Analysis of NCIC CTG CO.17 and CO.20  Academic Article
• Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma  Academic Article
• PET Changes Management and Improves Prognostic Stratification in Patients with Head and Neck Cancer: Results of a Multicenter Prospective Study  Academic Article
• PIK3CA, BRAF, and PTEN status and benefit from cetuximab in the treatment of advanced colorectal cancer-results from NCIC CTG/AGITG CO.17  Academic Article
• PTEN gene expression and mutations in the PIK3CA gene as predictors of clinical benefit to anti-epidermal growth factor receptor antibody therapy in patients with KRAS wild-type metastatic colorectal cancer  Academic Article
• Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial  Academic Article
• Panitumumab added to docetaxel, cisplatin and fluoropyrimidine in oesophagogastric cancer: ATTAX3 phase II trial  Academic Article
• Partial orchiectomy for presumed malignancy in patients with a solitary testis due to a prior germ cell tumor: A large North American experience  Academic Article
• Patterns of care and outcomes for elderly patients with metastatic colorectal cancer in Australia  Academic Article
• Patterns of care for metastatic renal cell carcinoma in Australia  Academic Article
• Phase II randomized, double-blind, placebo-controlled study of AMG 386 (trebananib) in combination with cisplatin and capecitabine in patients with metastatic gastro-oesophageal cancer  Academic Article
• Phase II study of first‐line trebananib plus sorafenib in patients with advanced hepatocellular carcinoma  Academic Article
• Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma  Academic Article
• Poor prognosis of patients with triple-negative breast cancer can be stratified by RANK and RANKL dual expression  Academic Article
• Positron emission tomography changes management and prognostic stratification in patients with oesophageal cancer: results of a multicentre prospective study  Academic Article
• Positron emission tomography changes management, improves prognostic stratification and is superior to gallium scintigraphy in patients with low-grade lymphoma: results of a multicentre prospective study  Academic Article
• Predicting Clinical Outcome through Molecular Profiling in Stage III Melanoma  Academic Article
• Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer  Academic Article
• Prognostic Implications of Exercise Echocardiography in Women With Known or Suspected Coronary Artery Disease  Academic Article
• Prognostic Significance of Exercise-induced Right Ventricular Dysfunction in Asymptomatic Degenerative Mitral Regurgitation  Academic Article
• Prognostic Value of 18F-FDG PET/CT in Patients with Malignant Pleural Mesothelioma  Academic Article
• Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review  Academic Article
• Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma  Academic Article
• Randomized phase II trial of parsatuzumab (Anti‐EGFL7) or placebo in combination with FOLFOX and bevacizumab for first‐line metastatic colorectal cancer  Academic Article
• Regorafenib for the treatment of advanced gastric cancer (INTEGRATE): A multinational placebo-controlled phase II Trial  Academic Article
• Reporting of Time-to-Event End Points and Tracking of Failures in Randomized Trials of Radiotherapy With or Without Any Concomitant Anticancer Agent for Locally Advanced Head and Neck Cancer  Academic Article
• Rilotumumab plus epirubicin, cisplatin, and capecitabine as first-line therapy in advanced MET-positive gastric or gastro-oesophageal junction cancer (RILOMET-1): a randomised, double-blind, placebo-controlled, phase 3 trial  Academic Article
• Risk stratification of patients with medically treated unstable angina using exercise echocardiography  Academic Article
• Significance of molecular marker-positive cells after autologous peripheral-blood stem-cell transplantation for non-Hodgkin's lymphoma.  Academic Article
• Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis  Academic Article
• Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029) : an open-label, phase 1b trial  Academic Article
• Survival and Complications Following Surgery and Radiation for Localized Prostate Cancer: An International Collaborative Review  Academic Article
• Survival outcomes in elderly men undergoing radical prostatectomy in Australia  Academic Article
• Survival outcomes in renal transplant recipients with renal cell carcinoma or transitional cell carcinoma from the ANZDATA database  Academic Article
• TACTIC: a multicentre, open-label, single-arm phase II trial of panitumumab, cisplatin, and gemcitabine in biliary tract cancer  Academic Article
• Telomere length is a novel predictive biomarker of sensitivity to anti-EGFR therapy in metastatic colorectal cancer  Academic Article
• The Role of Surveillance CT Scans in Patients with Diffuse Large B-cell Non-Hodgkin's Lymphoma  Academic Article
• The cost effectiveness of bevacizumab when added to capecitabine, with or without mitomycin-C, in first line treatment of metastatic colorectal cancer: Results from the Australasian phase III MAX study  Academic Article
• The effects of nonspecific HIF1α inhibitors on development of castrate resistance and metastases in prostate cancer  Academic Article
• The relationship between rash, tumour KRAS mutation status and clinical and quality of life outcomes in patients with advanced colorectal cancer treated with cetuximab in the NCIC CTG/AGITG CO.17  Academic Article
• The relative importance of vascular structure and function in predicting cardiovascular events  Academic Article
• The role of BRAF mutations in primary melanoma growth rate and survival  Academic Article
• The role of biological therapy in metastatic colorectal cancer after first-line treatment: a meta-analysis of randomised trials  Academic Article
• The role of focal therapy in the management of localised prostate cancer: A systematic review  Academic Article
• Tumour but not stromal expression of β 3 integrin is essential, and is required early, for spontaneous dissemination of bone-metastatic breast cancer  Academic Article
• Ultrasound-Guided Injection of Polidocanol Microfoam in the Management of Venous Leg Ulcers  Academic Article
• Updated Analysis of RTOG 94-13: In Regard to Lawton et al. (Int J Radiat Oncol Biol Phys 2007;69:646–655)  Academic Article
• Use of dobutamine echocardiography for cardiac risk stratification of patients with chronic renal failure  Academic Article
• What defines intermediate-risk prostate cancer? Variability in published prognostic models  Academic Article